Financial Performance Summary - In 2025, the company achieved operating revenue of 2.33 billion RMB, representing a year-on-year growth of 2.0%, with a notable 13.1% increase in the fourth quarter [2] - The company's overseas revenue reached 840 million RMB, up 17.9% year-on-year, accounting for 36% of total revenue, an increase of 5 percentage points from 2024 [2] - Domestic revenue was 1.47 billion RMB, down 5.5% year-on-year, but showed recovery with a 14.5% increase in the fourth quarter [2] Growth Drivers - The growth was primarily driven by accelerated globalization, with localized operations in 18 countries and over 400 product certifications abroad [2] - The company reported significant growth in new industries, with new industry revenue accounting for 48.5% of total revenue, growing by 8.8% year-on-year [3] - The AI-related revenue constituted 15% of total revenue, an increase of 2.5 percentage points from 2024, indicating a strong integration of AI and automation technologies [5] Profitability and Challenges - The net profit attributable to shareholders was 250 million RMB, a decline of 31.6% year-on-year, influenced by external market conditions and strategic investments [5] - The gross profit margin was 46.8%, affected by the ramp-up of new production capacity, with a slight improvement of approximately 0.7 percentage points in the fourth quarter [5] - The company faced challenges such as trade frictions and the need for ongoing investments in globalization and innovation, which impacted profitability [6]

数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 北京玄薇生物医疗科技有限公司（简称"玄薇医疗"），是一家聚焦肿瘤精准医疗领域的创新型科技企 业，以"AI赋能精准医疗"为核心定位，以"数据驱动优化肿瘤治疗及临床实践"为核心使命，聚焦肿瘤免 疫治疗毒性反应这一关键痛点，致力于成为国内领先的肿瘤专病数据及智能辅助诊疗服务提供商。 证券之星消息，根据天眼查APP于2月24日公布的信息整理，北京玄薇生物医疗科技有限公司种子轮融 资，融资额未披露，参与投资的机构包括梅花创投。 ...

每经讯，海能技术2月25日发布公告称，根据海能未来技术集团股份有限公司发展战略及经营规划，公 司拟与铭晔管理咨询（上海）有限公司共同出资设立元神生物医疗科技（上海）有限公司，注册地位于 上海市，注册资本为200万元，其中，公司以自有资金出资20万元，持股占比10%；铭晔管理咨询（上 海）有限公司以自有资金出资180万元，持股占比90%。 （记者 曾健辉） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 ...

新年开新篇，奋进启新程。 在"十五五"开局之年，全国各地涌动实干热潮，各行各业抢抓开局、聚力攻坚，从科技创新研发到 企业生产一线，从项目建设现场到消费市场前沿，发展的活力持续迸发，为2026年经济发展筑好基、开 好局。 在服务新产业中发展新产业 浙江杭州，在算力与新材料赛道，传化集团旗下新安股份交出了硅基液冷领域技术与商用双突破的 新年答卷。 "我们依托60年有机硅材料研发与工程化经验，成功开发出具备高绝缘性、极低挥发性、优异热稳 定性及环境友好特性的硅基冷却液，完美适配浸没式液冷的严苛要求。"新安股份硅基新材料研究院院 长刘继指着浸没在透明冷却液中的服务器，详细讲解硅基液冷解决方案的细节。 针对数据中心、储能安全、超快充电等不同高热场景，新安股份已形成系列化产品矩阵，覆盖从材 料到系统的全链条，首个硅基浸没液冷商用项目在杭州稳定运行，其在新技术、新场景、新产业领域的 探索步伐还在继续。 眼下，液冷成为算力刚需，硅基材料凭借性能、成本与环保三重优势，成为液冷产业化的核心支 撑，市场空间加速打开，2026年有望迎来液冷产业化放量的关键节点。 "应用场景越多样、需求越细分，发展潜力就越大。"刘继充满信心地说，"今 ...

【大湾观察】 光明日报记者 党文婷 严圣禾 近日，由深圳市前海管理局与香港人才服务办公室联合主办的"第十二届深港（前海）人才合作年会"圆 满落幕。会上，象征深港服务一体化的"湾区人才通"平台正式亮相，全新成立的"深港HR联盟"同步启 动，一系列重磅举措与服务平台的推出，让深港人才融合发展迈向新的阶段。 回望过去一年，深圳与香港紧密协作，双方"携手出海"，面向全球人才发出"橄榄枝"，一系列创新举措 打破深港人才流动壁垒——让人才无需在深港间做单选题，助力粤港澳大湾区打造规则衔接、资源互 通、机遇共享的区域创新共同体，共同构筑起大湾区吸引国际人才的"强磁场"。 携手出海，扩大国际引才"朋友圈" "这里有大型科技企业、优秀的高校、良好的初创生态系统，还有活跃的国际社区，而且新政策让外国 人来中国发展更加便捷。"法国强生医疗高级总监拉姆齐在使用了"深港72小时体验券"后，向记者畅谈 自己的感受。深耕生物医疗领域20余年、曾在全球多地工作的他，在大湾区看到了未来十年创新发展的 无限可能。 "我计划把自己的行业经验带到这里，与本地的政府、高校、初创企业深度合作，要么设立咨询公司， 要么创办一家初创企业，这是我明确的目标。 ...

经济观察网 近一周（2026年2月9日至13日），Ping An Biomedical Co., Ltd. (PASW.OQ) 股价波动剧烈， 成为主要关注点。根据内部数据库行情数据，2月9日股价大幅上涨21.82%至0.27美元，成交额达109.61 万美元，换手率17.59%；但随后三个交易日连续回调，2月10日下跌5.22%至0.25美元，2月11日下跌 5.12%至0.24美元，2月12日进一步下跌9.13%至0.22美元；2月13日反弹3.65%至0.23美元。区间振幅高达 30%，累计换手率超50%，显示低流动性放大价格波动。同期所属纺织制造板块微涨0.24%，美股纳斯 达克指数上涨0.39%，个股表现显著独立于板块及大盘。 以上内容基于公开资料整理，不构成投资建议。 ...

以上内容基于公开资料整理，不构成投资建议。 股票近期走势 当日，美国三大股指全线收跌，纳斯达克指数下跌2.03%，标普500指数下跌1.57%，道琼斯指数下跌 1.34%。科技股普遍承压，市场对人工智能可能带来的行业颠覆性影响感到担忧，同时美国成屋销售数 据不佳也加剧了避险情绪，导致资金从风险资产流出。在此背景下，该股当日收盘下跌9.13%，报0.22 美元，振幅为13.42%。 经济观察网根据公开信息，Ping An Biomedical Co.,Ltd.(股票代码：PASW.OQ)在2026年2月12日股价下 跌主要受整体市场环境影响。 ...

Core Viewpoint - The Shanghai International Commercial Court has made significant progress in its first year of operation, handling a total of 2,161 cases with a total amount in dispute exceeding 30 billion yuan by the end of 2025 [3][4]. Group 1: Case Handling and Statistics - The court has resolved 1,743 cases, with a diverse range of parties involved from 56 countries and regions across five continents [3][4]. - The main areas of dispute include international sales contracts, foreign service contracts, foreign contracting disputes, foreign equity transfer disputes, and foreign loan contracts [3][4]. - Specific industries involved in disputes include cross-border investment (131 cases), integrated circuits (120 cases), biomedicine (119 cases), shipping and logistics (73 cases), and enterprises "going global" (65 cases) [3][4]. Group 2: International Judicial Cooperation - The court has prioritized international mutual recognition, handling 30 international judicial assistance cases in 2025, marking a 130% increase year-on-year, with a total amount in dispute of 3.83 billion yuan [4]. - The court has contributed to the construction of international commercial rules, with 13 cases from 2025 included in well-known international databases [4][5]. Group 3: Characteristics of Foreign-related Disputes - Foreign-related business types for enterprises include overseas investments, such as establishing companies or acquiring equity, and undertaking local projects, particularly in "Belt and Road" countries [6]. - Recommendations for enterprises "going global" include resolving disputes through mediation, enhancing compliance systems, and being aware of currency exchange risks [6].

Core Insights - The Shanghai International Commercial Court has processed 2,161 cases and concluded 1,743 cases within its first year, with a total amount in dispute exceeding 30 billion yuan [1] - The court's jurisdiction covers parties from 56 countries and regions, with major dispute areas including international sales contracts, foreign service contracts, and cross-border investment [1][2] - The court has seen a 130% year-on-year increase in international judicial assistance cases, with 30 cases accepted in 2025, involving a total amount of 3.83 billion yuan [2] Group 1 - The Shanghai International Commercial Court aims to promote international recognition through the implementation of international judicial assistance systems [2] - The court has contributed to the construction of international commercial rules, with 13 cases from 2025 included in renowned international databases [2] - The court's annual report includes a list of ten typical cases that reflect the understanding and application of international conventions by frontline judges [2] Group 2 - Characteristics of foreign-related disputes include investments abroad and local business contracts, particularly in Belt and Road countries [3] - Recommendations for companies "going global" include resolving disputes through mediation, enhancing compliance systems, and being aware of currency exchange risks [3] - Companies should establish clear dispute resolution agreements to avoid prolonged arbitration processes, as illustrated by a case involving a share transfer in Cambodia [3]

Core Insights - The article highlights that Jiangsu Province led the nation in IPOs in 2025, with 46 companies listed, accounting for 15% of the national total [5][6][11] - The report emphasizes the long-term development of Jiangsu's capital efficiency and industrial ecosystem, which has resulted in a significant increase in IPO activity [6][19] Summary by Sections IPO Data Overview - In 2025, a total of 294 IPOs occurred nationwide, with Jiangsu Province achieving the highest number [5] - The total IPO amount for Jiangsu reached 40.858 billion yuan, more than doubling from the previous year [6] Industry Distribution - The majority of IPOs in Jiangsu were concentrated in advanced manufacturing, healthcare, and energy/mining, which together accounted for 71.8% of the total [8] - Notable companies include Jiangsu's largest IPO, United Power, valued at approximately 66 billion yuan, and Qiangyi Co., valued at 48 billion yuan [10] Regional Insights - Suzhou emerged as the leading city in Jiangsu with 19 IPOs, representing 41.3% of the province's total [11] - Jiangsu's IPOs were distributed across 11 cities, with significant contributions from cities like Wuxi and Changzhou [11][13] Long-term Trends - Over the past five years, Jiangsu has facilitated the listing of 265 companies, establishing itself as a key player in the capital market [18][21] - The province's investment events have increased significantly, from 272 in 2013 to nearly 2000 in recent years, indicating a robust investment environment [20] Role of Venture Capital - A high percentage of IPO companies in Jiangsu (87%) had received VC/PE investment, surpassing the national average of 57.8% [19] - Local investment institutions have been active, with five of the top ten direct investment institutions in China based in Jiangsu [25] Future Outlook - Jiangsu has launched several large-scale investment funds, including a 50 billion yuan mother fund, which is expected to sustain investment activity in the coming years [26] - The province's entrepreneurial landscape is characterized by a high number of engineers as founders, focusing on practical industrial opportunities [34][36]